Magnus Corfitzen

Magnus Corfitzen Email and Phone Number

CEO at Ascelia Pharma AB @ Ascelia Pharma AB
Magnus Corfitzen's Location
Copenhagen, Capital Region of Denmark, Denmark, Denmark
Magnus Corfitzen's Contact Details

Magnus Corfitzen personal email

n/a
About Magnus Corfitzen

Extensive experience from the last 20+ years in investing, building and growing life science companies in various roles including operational activities or investment responsibilities in public or private biotech or medtech companies. Magnus has served on the board of directors of 12 companies in various segments of the life science arena across many therapeutic areas.With a focus on building sustainable businesses, Magnus is highly active in creating corporate and product strategies, which serve unmet needs and can be financed and implemented to create long term shareholder value. Over the years he has been involved in a significant number of financing and business development transactions.

Magnus Corfitzen's Current Company Details
Ascelia Pharma AB

Ascelia Pharma Ab

View
CEO at Ascelia Pharma AB
Magnus Corfitzen Work Experience Details
  • Ascelia Pharma Ab
    Ceo
    Ascelia Pharma Ab 2017 - Present
    Malmö, Skane County, Se
    Ascelia is a specialty pharmaceutical company located in Malmö, Sweden dedicated to the development of novel medicines to improve the life expectancy and quality of life for people living with cancer. The Company’s strategy is to develop and make available to patients a portfolio of differentiated, underappreciated and de-risked medicinal product candidates addressing unmet medical needs in cancer and cancer-related diseases.Ascelia has two clinical stage product candidates under development: Mangoral and Oncoral.
  • Ascelia Pharma Ab
    Ceo
    Ascelia Pharma Ab Jul 2014 - 2017
    Malmö, Skane County, Se
    CMC Contrast AB is a privately owned biotech company developing CMC-001, a novel liver MRI contrast agent for use in patients at risk of serious side effects from gadolinium based contrast agents. The drug has been tested in 6 clinical studies and has orphan drug designation from FDA.
  • Sunstone Life Science Ventures
    Investment Director - Life Science Ventures
    Sunstone Life Science Ventures May 2007 - Jun 2014
    Copenhagen, Capital Region, Dk
    Sunstone Capital is a European venture capital firm founded in 2007 and has approximately EUR 700 million under management.
  • Cmc Contrast Ab
    Interim Ceo
    Cmc Contrast Ab 2011 - Apr 2012
    Malmö, Skane County, Se
    CMC Contrast AB is a privately owned drug development company developing CMC-001, a novel contrast agent for use in liver MRI in patients where gadolinium based contrast agents are contraindicated or cannot be administered due to risk of serious side effects such as Nephrogenic Systemic Fibrosis.
  • Vaekstfonden
    Investment Director - Life Science Ventures
    Vaekstfonden Nov 2002 - May 2007
    Copenhagen, Capital Region Of Denmark, Dk
    Vaekstfonden is a EUR 400 million state owned investment fund investing in early stage companies.
  • Danske Bank
    Portfolio Manager Biotechnology And Medtech
    Danske Bank Aug 2000 - Oct 2002
    Copenhagen, Capital Region Of Denmark, Dk
    Danske Capital is the asset management division of the Danske Bank group with EUR 50 billion under management.
  • Mckinsey & Company
    Consultant
    Mckinsey & Company May 1999 - Jun 2000
    Us
    McKinsey & Company is a global management consulting firm advising the world's leading businesses, governments and institutions.

Magnus Corfitzen Skills

Venture Capital Start Ups Strategy Due Diligence Biotechnology Investments Business Strategy Pharmaceutical Industry Business Development Financial Modeling Life Sciences Medical Devices Corporate Development Market Analysis Private Equity Entrepreneurship Mergers And Acquisitions Portfolio Management Lifesciences Capital Markets Valuation Growth Capital Commercialization Corporate Finance M&a Experience Asset Management Venture Financing Finance Drug Development Emerging Markets Investor Relations Negotiation Ipo Biotechnology Industry Angel Investing Restructuring Orphan Drugs Regulatory Strategy Development

Magnus Corfitzen Education Details

  • Aarhus University
    Aarhus University
    Mathematical Economics
  • Harvard University
    Harvard University
    Corporate Governance & International Business

Frequently Asked Questions about Magnus Corfitzen

What company does Magnus Corfitzen work for?

Magnus Corfitzen works for Ascelia Pharma Ab

What is Magnus Corfitzen's role at the current company?

Magnus Corfitzen's current role is CEO at Ascelia Pharma AB.

What is Magnus Corfitzen's email address?

Magnus Corfitzen's email address is co****@****tal.com

What schools did Magnus Corfitzen attend?

Magnus Corfitzen attended Aarhus University, Harvard University.

What skills is Magnus Corfitzen known for?

Magnus Corfitzen has skills like Venture Capital, Start Ups, Strategy, Due Diligence, Biotechnology, Investments, Business Strategy, Pharmaceutical Industry, Business Development, Financial Modeling, Life Sciences, Medical Devices.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.